Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker study

Vianello, Eleonora; Gonzalez-Dias, Patricia; van Veen, Suzanne; Engele, Carmen G; Quinten, Edwin; Monath, Thomas P; Medaglini, Donata; Santoro, Francesco; Csaki Huttner, Angela; Dubey, Sheri; Eichberg, Michael; Ndungu, Francis M; Kremsner, Peter G; Essone, Paulin N; Agnandji, Selidji Todagbe; Siegrist, Claire-Anne; Nakaya, Helder I; Ottenhoff, Tom H M; Haks, Mariëlle C; VSV-EBOVAC Consortium; VSV-EBOPLUS Consortium

doi:10.1016/S2666-5247(21)00235-4

Scientific article

English

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker study

ContributorsVianello, Eleonora; Gonzalez-Dias, Patricia

; van Veen, Suzanne; Engele, Carmen G; Quinten, Edwin; Monath, Thomas P; Medaglini, Donata; Santoro, Francesco; Csaki Huttner, Angela; Dubey, Sheri; Eichberg, Michael; Ndungu, Francis M; Kremsner, Peter G; Essone, Paulin N; Agnandji, Selidji Todagbe; Siegrist, Claire-Anne; Nakaya, Helder I; Ottenhoff, Tom H M; Haks, Mariëlle C; VSV-EBOVAC Consortium; VSV-EBOPLUS Consortium

Published inThe Lancet microbe, vol. 3, no. 2, p. e113-e123

Publication date2022-02

Affiliation entities

Research groups

Citation (ISO format)

VIANELLO, Eleonora et al. Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker study. In: The Lancet microbe, 2022, vol. 3, n° 2, p. e113–e123. doi: 10.1016/S2666-5247(21)00235-4